Skip to main content
. 2019 Mar 7;9(3):e023463. doi: 10.1136/bmjopen-2018-023463

Table 1.

Characteristics of patients receiving non-curative chemotherapy

First line (n=12) Second line (n=8)
Women 5 3
Men 7 5
Mean age (range), years 63 (34–75) 69 (64–75)
Marital status:
 Married/cohabiting 10 8
 Single 1
 Widow/widower 1
Chemotherapy used
 Fliri/bevacizumab 10
 FLOX (5-fluorouracil, folinic acid, oxaliplatin) 1 8
 Capecitabine plus oxaliplatin (Xelox) 1

All paticipants received 5-fluorouracil-based combination chemotherapy with irinotecan or oxaliplatin, ±bevacizumab.